Department of Urology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211027915. doi: 10.1177/15330338211027915.
CARD-containing MAGUK protein 3 (CARMA3) is associated with tumor occurrence and progression. However, the signaling pathways involved in CARMA3 function remain unclear. We aimed to analyze the association between CARMA3 and stathmin (STMN1) through the NF-κB pathway, which is associated with cell proliferation and invasion, in clear cell renal cell carcinoma (ccRCC). We evaluated the effects of CARMA3 and STMN1 expression on cell migration, proliferation, and invasion in various cell lines, and their expression in tissue samples from patients with ccRCC. CARMA3 was highly expressed in ccRCC tissues and cell lines. Moreover, CARMA3 promoted the proliferation and invasion of RCC cells by activating the NF-κB pathway to transcribe STMN1. Stathmin exhibited a consistent profile with CARMA3 in ccRCC tissue, and could be an effector for CARMA3-activated cell proliferation and invasion of ccRCC cells. In summary, CARMA3 may serve as a promising target for ccRCC treatment.
含 CARD 的 MAGUK 蛋白 3(CARMA3)与肿瘤的发生和进展有关。然而,CARMA3 功能涉及的信号通路仍不清楚。我们旨在通过与细胞增殖和侵袭相关的 NF-κB 通路分析 CARMA3 与 stathmin(STMN1)之间的关联,在透明细胞肾细胞癌(ccRCC)中。我们评估了 CARMA3 和 STMN1 表达在不同细胞系中的细胞迁移、增殖和侵袭中的作用,以及它们在 ccRCC 患者组织样本中的表达。CARMA3 在 ccRCC 组织和细胞系中高表达。此外,CARMA3 通过激活 NF-κB 通路转录 STMN1 促进 RCC 细胞的增殖和侵袭。Stathmin 在 ccRCC 组织中与 CARMA3 具有一致的特征,并且可能是 CARMA3 激活的 ccRCC 细胞增殖和侵袭的效应物。总之,CARMA3 可能成为 ccRCC 治疗的有希望的靶点。